## Assessment of Vaccine Response in Immunisation Programs ### Clinical Context The question addresses verification of immunological response to DPT vaccine in a child who has received the first dose but missed the second dose. ### Investigation of Choice: Serum Anti-diphtheria Toxoid IgG Antibody Titre **Key Point:** Serological testing for specific antibodies (anti-diphtheria, anti-tetanus, anti-pertussis IgG) is the gold standard to confirm seroconversion and protective immunity following DPT vaccination. **High-Yield:** In India's Universal Immunisation Programme (UIP), when vaccine response is in question: - Serological titres measure actual immunological response - Protective antibody levels are well-defined: ≥0.1 IU/mL for diphtheria and tetanus is considered protective - This guides decision on whether to administer catch-up doses or additional booster doses ### Why Serological Testing? | Aspect | Serological Testing | Other Investigations | |--------|-------------------|---------------------| | **Measures** | Specific antibody response to vaccine | General immune status or local reaction | | **Indicates** | Seroconversion & protective immunity | Non-specific findings | | **Guides** | Catch-up schedule & booster timing | Clinical diagnosis only | | **Specificity** | 100% for vaccine response | Low for vaccine assessment | **Clinical Pearl:** Before administering catch-up doses in a child with missed vaccinations, serological confirmation of prior dose response prevents unnecessary over-vaccination and documents immune status in the child's health record. ### Mnemonic: **SERO** for Serological Assessment - **S**pecific antibodies measured - **E**valuates seroconversion - **R**eliable protective titre determination - **O**ptimal for vaccine response verification [cite:Park 26e Ch 7]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.